| Barnesiella viscericola| Barnesiella viscericola Sakamoto et al. 2007| DSM 18177| JCM 13660| strain C46
Gut Microbiota Composition: Barnesiella viscericola is a bacterium found in the human gut microbiota. The overall composition of the gut microbiota is crucial for maintaining a healthy digestive system, and different bacterial species contribute to various aspects of gut function.
Butyrate Production: Some members of the Barnesiella genus have been associated with the production of short-chain fatty acids, particularly butyrate. Butyrate is known for its potential benefits, including providing energy for colonocytes (cells lining the colon) and contributing to the maintenance of a healthy gut barrier.
Immunomodulation: Certain gut bacteria, including members of the Barnesiella genus, may play a role in modulating the immune system. The interaction between gut bacteria and the immune system is complex, and specific species can have different effects on immune function.
Influence on Inflammation: Some research suggests that certain species within the Barnesiella genus may have anti-inflammatory properties. Inflammation in the gut is associated with various gastrointestinal conditions, and the balance of pro- and anti-inflammatory bacteria is critical for gut health.
Dietary Influences: The composition of the gut microbiota, including the presence of species like Barnesiella viscericola, can be influenced by diet. Dietary factors, such as the consumption of fiber and certain types of carbohydrates, may impact the abundance and activity of specific bacteria in the gut.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 1.72 | 10 | 23080 | 0 | 11833 | 1878.4 | 400 | 5078.7 | 0 | 1800 | 0 %ile | 100 %ile | ||
thorne | 100 | 64 | 2145 | 0 | 1281 | 464.7 | 363 | 416.6 | 3 | 931 | 0 %ile | 100 %ile | ||
thryve | 29.42 | 0 | 17 | 1 | 345 | 0 | 1782 | 300.4 | 42 | 755.8 | 0 | 416 | 0 %ile | 91.7 %ile |
ubiome | 0.25 | 213 | 3806 | 0 | 6989 | 2009.5 | 2010 | 2540.6 | 213 | 3806 | 25 %ile | 50 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
XenoGene | 100 | 15000 | 0.01 | 1.5 |
Thorne (20/80%ile) | 236.62 | 690.12 | 0.0237 | 0.069 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSightRdp | 25 % | 0.046 % | 0.07 % | 8.0 | 32 |
CerbaLab | 100 % | 0.04 % | 0.045 % | 3.0 | 3 |
CosmosId | 12.5 % | 0.007 % | 0.004 % | 4.0 | 32 |
custom | 18.644 % | 0.059 % | 0.036 % | 11.0 | 59 |
es-xenogene | 96.552 % | 0.267 % | 0.586 % | 28.0 | 29 |
SequentiaBiotech | 5.556 % | 0.035 % | 0.014 % | 2.0 | 36 |
Thorne | 85.556 % | 0.03 % | 0.033 % | 77.0 | 90 |
Thryve | 29.284 % | 0.027 % | 0.067 % | 405.0 | 1383 |
uBiome | 0.253 % | 0.201 % | 0.254 % | 2.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.